Aclaris Therapeutics, Inc.【ACRS】 業績推移・財務諸表

(単位:千ドル) 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 - - - - - - - 684 999 1,118 3,676 1,628 3,669 5,041 5,865 983 1,407 2,046 1,449 1,777 1,824 1,659 1,453 1,528 19,018 2,528 1,869 9,282 2,398 2,766 4,346 1,455
売上成長率(%) - - - - - - - - - - -
売上原価 - - - - - - - 453 - 967 1,181 1,193 - 2,777 2,703 826 1,269 1,389 1,189 1,202 1,263 1,099 1,155 1,068 923 808 1,042 848 809 624 654 506
売上総利益 - - - - - - - 231 245 151 2,495 435 160 - - - - - - - - - - - - - - - - - - -
売上総利益率(%) - - - - - - - - - - - - - - - - - - - - - - - - - -
研究開発費 - 9,535 9,836 7,162 - 7,772 7,965 10,864 - 13,606 13,984 15,931 - 19,919 17,622 16,183 9,444 6,466 6,866 7,838 7,897 13,976 14,306 18,779 23,656 22,587 25,275 23,876 9,845 8,759 5,956 11,584
営業費用 4,802 13,139 12,989 10,812 11,627 12,930 15,295 18,987 25,687 31,099 34,473 33,885 39,198 42,376 55,656 23,847 16,913 - - 30,306 19,830 21,954 20,360 22,522 39,892 32,446 33,684 40,859 21,329 15,620 14,817 19,539
営業利益 - -13,139 -12,989 -10,812 - -12,930 -15,295 -18,756 - -30,948 -31,978 -33,450 - -37,335 -49,791 -22,864 -15,506 -11,381 -10,465 -28,529 -18,006 -20,295 -18,907 -20,994 -20,874 -29,918 -31,815 -31,577 -18,931 -12,854 -10,471 -18,084
営業利益率 (%) - - - - - - - - -
純利益 -4,714 -13,039 -12,871 -10,694 -11,475 -12,559 -14,838 -18,192 - -30,229 -31,218 -32,740 -38,551 -37,565 -49,876 -55,319 -15,586 -11,597 -10,659 -28,754 -18,161 -21,146 -18,789 -20,532 -19,952 -28,160 -29,569 -29,261 -16,941 -10,986 -7,586 -15,085
純利益率(%) - - - - - - - -
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - -0.31 -0.31 -0.3 -0.42 -0.42 -0.41 -0.24 -0.15 -0.11 -0.12
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - -0.31 -0.31 -0.3 -0.42 -0.42 -0.41 -0.24 -0.15 -0.11 -0.12
EBITDA - - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - -